Qiyi Zhao
12PUBLICATIONS
25CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Apr 02, 2026
Metabolic engineering of SLC38A2 reprograms glutamine utilization and enhances CAR-macrophage antitumor function in solid tumors.Mingzhu Liu, Qingxi Chen, Luoling Zhang
|Mar 27, 2026
Therapeutic Prospects of Artificially Synthesized Circular RNA.Hui Chen, Yi Du, Yesheng Wang
|May 31, 2025
Correction: Nucleos(t)ide analogs continuation is not associated with a lower risk of HBsAg seroreversion following PEG-IFN-induced HBsAg loss.Na Gao, Haishi Wu, Bin Li
|Mar 20, 2025
Nucleos(t)ide analogs continuation is not associated with a lower risk of HBsAg seroreversion following PEG-IFN-induced HBsAg loss.Na Gao, Haishi Wu, Bin Li
|Oct 27, 2023
Editorial: HBsAg seroclearance after pegylated interferon treatment-The beginning of the end. Authors' reply.Na Gao, Guiwen Guan, Qiyi Zhao
|Aug 30, 2023
Integrated HBV DNA and cccDNA maintain transcriptional activity in intrahepatic HBsAg-positive patients with functional cure following PEG-IFN-based therapy.Na Gao, Guiwen Guan, Ganlin Xu
Pageof 2
